(Setting aside the Marketing aspects) Sounds like they are still in Clinical Trials in US, but are allowed to concurrently start Clinicals in India. Hopefully that means that the US Clinicals are still looking good, tho it's not a LT track record yet. Thanks to all the courageous Clinical...